200 Stuart Street
Boston, Massachusetts

Hosted by Hanson Wade, the World Antibody Manufacturing & Development Summit aims to bring together thought leaders to drive antibody development forward. The event will provide market intelligence on the biosimilar landscape, updates on the post-approval lifecycle management (PALM) plan that is being developed for antibody products undergoing licensing with QbD, strategies for rapid transfer of protein therapeutics into existing manufacturing facilities, design tips for enhancing CMC probability of success, and advice on how to implement single-use processing across all unit operations.

Tim Tousey will present on "Maximizing flexibility & reliability in biopharmaceutical manufacture."

Added by MedImmune on May 19, 2011

Interested 1